Joey Azofeifa

Joey Azofeifa is the CEO and co-founder of Arpeggio Bio, a biotech startup focused on fighting drug resistance in cancer.2 Here are some key details about Joey:

Professional Background

Joey has a diverse background spanning biology, computer science, and data science:

• He founded Arpeggio Bio in February 2019 and has since raised over $20 million in venture funding.24
• Prior to Arpeggio, he worked as a Data Scientist at Forma Therapeutics and as a Bioinformatics Scientist at Merck.2
• He has extensive experience in machine learning, probabilistic modeling, data visualization, and database management.3

Education

• Ph.D. in Computer Science from the University of Colorado Boulder, focusing on applying machine learning to massive transcriptomic datasets.1
• Undergraduate degree in Biology from Vassar College.3

Achievements and Recognition

• Named to Forbes 30 Under 30 in Healthcare in November 2019.2
• Selected for Colorado BizWest's 40 Under 40 in September 2023.2
• Participated in Y Combinator's S19 batch.3

Arpeggio Bio

Under Joey's leadership, Arpeggio Bio has:

• Developed an automated laboratory that profiles thousands of drugs for changes in RNA.2
• Built the world's largest database of nascent RNA drug profiles.2
• Partnered with over 40 pharmaceutical companies, including Novartis, Pfizer, and Genentech.2
• Focused on developing new medicines to alter gene expression and combat drug resistance in cancer.5

Joey's work at Arpeggio Bio combines his expertise in bioinformatics, AI, and molecular biology to advance drug discovery and improve our understanding of human disease.1